» Articles » PMID: 39575120

GENERATIVE FORECASTING OF BRAIN ACTIVITY ENHANCES ALZHEIMER'S CLASSIFICATION AND INTERPRETATION

Overview
Journal ArXiv
Date 2024 Nov 22
PMID 39575120
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the relationship between cognition and intrinsic brain activity through purely data-driven approaches remains a significant challenge in neuroscience. Resting-state functional magnetic resonance imaging (rs-fMRI) offers a non-invasive method to monitor regional neural activity, providing a rich and complex spatiotemporal data structure. Deep learning has shown promise in capturing these intricate representations. However, the limited availability of large datasets, especially for disease-specific groups such as Alzheimer's Disease (AD), constrains the generalizability of deep learning models. In this study, we focus on multivariate time series forecasting of independent component networks derived from rs-fMRI as a form of data augmentation, using both a conventional LSTM-based model and the novel Transformer-based BrainLM model. We assess their utility in AD classification, demonstrating how generative forecasting enhances classification performance. Post-hoc interpretation of BrainLM reveals class-specific brain network sensitivities associated with AD.

References
1.
Du Y, Fu Z, Sui J, Gao S, Xing Y, Lin D . NeuroMark: An automated and adaptive ICA based pipeline to identify reproducible fMRI markers of brain disorders. Neuroimage Clin. 2020; 28:102375. PMC: 7509081. DOI: 10.1016/j.nicl.2020.102375. View

2.
Gao Y, Lewis N, Calhoun V, Miller R . Interpretable LSTM model reveals transiently-realized patterns of dynamic brain connectivity that predict patient deterioration or recovery from very mild cognitive impairment. Comput Biol Med. 2023; 161:107005. PMC: 10365638. DOI: 10.1016/j.compbiomed.2023.107005. View

3.
Qiang N, Gao J, Dong Q, Yue H, Liang H, Liu L . Functional brain network identification and fMRI augmentation using a VAE-GAN framework. Comput Biol Med. 2023; 165:107395. DOI: 10.1016/j.compbiomed.2023.107395. View